[go: up one dir, main page]

ES446468A1 - Betaalactam containing compound - Google Patents

Betaalactam containing compound

Info

Publication number
ES446468A1
ES446468A1 ES446468A ES446468A ES446468A1 ES 446468 A1 ES446468 A1 ES 446468A1 ES 446468 A ES446468 A ES 446468A ES 446468 A ES446468 A ES 446468A ES 446468 A1 ES446468 A1 ES 446468A1
Authority
ES
Spain
Prior art keywords
formula
betaalactam
containing compound
see formula
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES446468A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB15209/75A external-priority patent/GB1545467A/en
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES446468A1 publication Critical patent/ES446468A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D503/02—Preparation
    • C07D503/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

A process for the preparation of new antibacterial agents of formula (III): ** (see formula) ** And salts and esters thereof, which consists in hydrogenating a compound of formula (IV): ** (see formula) ** Or an O-substituted derivative or a salt or ester thereof. (Machine-translation by Google Translate, not legally binding)
ES446468A 1975-04-14 1976-03-29 Betaalactam containing compound Expired ES446468A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB15209/75A GB1545467A (en) 1975-04-14 1975-04-14 Deoxyclavulanic acid and deoxyisoclavulanic acid and derivatives thereof
GB3967175 1975-09-27

Publications (1)

Publication Number Publication Date
ES446468A1 true ES446468A1 (en) 1977-11-01

Family

ID=26251136

Family Applications (1)

Application Number Title Priority Date Filing Date
ES446468A Expired ES446468A1 (en) 1975-04-14 1976-03-29 Betaalactam containing compound

Country Status (22)

Country Link
JP (1) JPS51127093A (en)
AR (1) AR208773A1 (en)
AT (1) AT342199B (en)
AU (1) AU497577B2 (en)
CA (1) CA1074802A (en)
CH (1) CH602742A5 (en)
DE (1) DE2616088A1 (en)
DK (1) DK144066C (en)
ES (1) ES446468A1 (en)
FI (1) FI760946A (en)
FR (1) FR2336130A1 (en)
GR (1) GR58256B (en)
HU (1) HU175444B (en)
IE (1) IE42666B1 (en)
IL (1) IL49279A (en)
LU (1) LU74749A1 (en)
MX (1) MX3453E (en)
NL (1) NL7603840A (en)
NO (1) NO761241L (en)
PT (1) PT64897B (en)
SE (1) SE427037B (en)
YU (1) YU69476A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7709876A (en) * 1976-09-09 1978-03-13 Glaxo Lab Ltd PROCESS FOR PREPARING NEW (BETA) PAINTINGS.
DE2747599A1 (en) * 1976-10-25 1978-04-27 Glaxo Lab Ltd CLAVULANIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS THEREOF
GB9007143D0 (en) * 1990-03-30 1990-05-30 Beecham Group Plc Veterinary composition

Also Published As

Publication number Publication date
FI760946A (en) 1976-10-15
FR2336130A1 (en) 1977-07-22
FR2336130B1 (en) 1979-06-22
AT342199B (en) 1978-03-28
GR58256B (en) 1977-09-15
DK144066C (en) 1982-05-10
MX3453E (en) 1980-12-03
JPS51127093A (en) 1976-11-05
CA1074802A (en) 1980-04-01
PT64897B (en) 1977-08-18
CH602742A5 (en) 1978-07-31
IE42666B1 (en) 1980-09-24
YU69476A (en) 1982-05-31
HU175444B (en) 1980-08-28
DK144066B (en) 1981-11-30
AU1302076A (en) 1977-10-20
NO761241L (en) 1976-10-15
IE42666L (en) 1976-10-14
LU74749A1 (en) 1976-11-11
ATA215576A (en) 1977-07-15
SE7604287L (en) 1976-10-15
DK156576A (en) 1976-10-15
AU497577B2 (en) 1978-12-21
IL49279A0 (en) 1976-06-30
IL49279A (en) 1979-05-31
AR208773A1 (en) 1977-02-28
DE2616088A1 (en) 1976-10-28
SE427037B (en) 1983-02-28
PT64897A (en) 1976-04-01
NL7603840A (en) 1976-10-18

Similar Documents

Publication Publication Date Title
ES462062A1 (en) Tetrahydroisoquinoline basic ethers and pharmaceutical compositions and methods employing them
ES457993A1 (en) Isothiazolo-pyridines
ES413266A1 (en) Indenyl compounds
ES446468A1 (en) Betaalactam containing compound
ES462849A1 (en) 4,4-dimethyl-3,5-pyrrolidinediones
ES446187A1 (en) Oxime ethers having anti-depressive activity
ES420638A1 (en) Quinoline derivatives
IL48708A (en) Fungicidal compositions containing 1-methyl-3,5-diphenyl-pyrazolium salts
ES462843A1 (en) Compound and production thereof
ES449841A1 (en) Agricultural composition incorporating derivatives of 7h-indolizino (7,6,5-de)-isoquinoline
ES402674A1 (en) Antibacterial agents and a process for the preparation thereof
ES390754A1 (en) 3-substituted-6-alkyl-2,3,6,9-tetrahydro-2,9-dioxothiazolo(5,4-f)-quinoline-8-carboxylic acids and methods for producing same
ES458389A1 (en) 8-azaprostaglandins and process for the preparation thereof
SU594611A1 (en) Bis(dimethylsulfonate)di-(1,3gamma-diethylaminopropanol ester) of alpha-truxillic acid for immobilizing animals
ES461191A1 (en) New nn**11piperidinyl*alkyl* aryl carboxysamide derivative
ES436104A1 (en) A process for the preparation of a substantially pure salt of an antibacterially active carboxylic acid compound. (Machine-translation by Google Translate, not legally binding)
ES402381A1 (en) Substituted benzopyrans and processes for their preparation
ES457780A1 (en) 7,10-dimethyl-5,9-imino-4,5,8,9-tetrahydro-cycloocta(b)-thiophenes
ES382147A1 (en) A procedure for preparing N-substituted morpholine compounds. (Machine-translation by Google Translate, not legally binding)
ES405105A1 (en) A process for the preparation of 2,6,6-trimethyl-1- (1 0'-carboxy-3 ', 7'-dimethyl-deca-1', 3 ', 5', 7 ', 9' - pentaenil) -cicolhexi-eno or a salt of the same. (Machine-translation by Google Translate, not legally binding)
ES457688A1 (en) New procedure for obtaining acid salts from addition of 3-phenyl-5-dietilamino-etil-1,2-4, -oxodiazol. (Machine-translation by Google Translate, not legally binding)
ES251959A1 (en) Procedure for obtaining a new derivative of morphine (Machine-translation by Google Translate, not legally binding)
ES462656A1 (en) A procedure for the preparation of cefalosporine derivatives. (Machine-translation by Google Translate, not legally binding)
ES320142A1 (en) A procedure for the preparation of penicillins. (Machine-translation by Google Translate, not legally binding)
ES324783A1 (en) Procedure for the manufacture of naphthalene derivatives. (Machine-translation by Google Translate, not legally binding)